CNIC

What CNIC does

CNIC (Centro Nacional de Investigaciones Cardiovasculares Carlos III) is a Madrid-based nonprofit research foundation (F.S.P.) operating as a public-private joint venture between the Spanish Government, through the Instituto de Salud Carlos III and the Ministerio de Ciencia e Innovación, and Fundación ProCNIC, a private foundation formed by 12 major Spanish companies and foundations. Refounded in its current configuration in 2006, CNIC conducts basic, translational, and clinical cardiovascular research across five focused programs: new mechanisms of atherosclerosis, myocardial homeostasis and cardiac damage, cardiovascular regeneration, cardiovascular and brain health, and technological development. The institution employs more than 450 researchers and technical staff and operates advanced infrastructure including genomics, proteomics, metabolomics, stem cell technology, viral vector platforms, transgenic animal models, flow cytometry, advanced microscopy, and clinical trial coordination.

The center's revenue model is non-commercial and rests on five funding streams: core government funding from Instituto de Salud Carlos III, private foundation support via Fundación ProCNIC, project-specific corporate research collaborations (notably Banco Santander's PESA CNIC2-SANTANDER project and Ferrer Internacional's Polypill initiative), competitive European research grants (including ERC Advanced Grants such as the €2.4M CARDIOSWITCH award), and tax-deductible scientific philanthropy. Research outputs are distributed through peer-reviewed scientific publications, an annual Scientific Report, the biannual CNIC Pulse magazine, a portfolio of 10 filed-pending patents covering cardiovascular diagnostics and therapeutics, technology transfer via the OTRI office, and structured training programs (CNIC-JOVEN plan, Acércate, InvesMIR, MD-PhD CNIC-SEC) developed in partnership with the Sociedad Española de Cardiología and Fundación Jiménez Díaz.

CNIC holds the Spanish Ministry's Severo Ochoa Centre of Excellence accreditation (2022–2025, €4M), the European Commission's HR Excellence in Research logo, and recognition as one of four leading cardiovascular research centres in Europe by the European Society of Cardiology. Its competitive positioning rests on a hybrid public-private funding structure rare in European biomedical research, internationally recognized scientific leadership (Valentín Fuster, Borja Ibáñez), proprietary methodologies in single-cell cardiomyocyte proteomics and cardiac regeneration, and a translational pipeline linking preclinical work to clinical trials through partner hospitals and imaging networks.

Name

CNIC

Legal name

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

Website

https://cnic.es

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

CNIC is a Madrid-based nonprofit cardiovascular research foundation operating as a Spanish Government and Fundación ProCNIC (12 private companies) joint venture, conducting basic, translational, and clinical cardiovascular research with 450+ staff and distributing outputs through publications, patents, and clinician-scientist training programs.

Ownership category

akta.pro rank

Product category

Cardiovascular Biomedical Research

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

Keywords

• Cardiovascular research
• Biomedical research
• Clinical trials
• Atherosclerosis research
• Cardiovascular training

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Public Government Funding: Core funding from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación through programs like Severo Ochoa Excellence accreditation
2. Private Foundation Funding: Funding from Fundación ProCNIC, formed by 12 major Spanish companies and private foundations; joint-venture model between government and private sector
3. Corporate Research Collaborations: Project-specific funding from corporate partners including Banco Santander (PESA project), Ferrer Internacional (Polypill), and others
4. Scientific Donations and Philanthropy: Tax-deductible donations from individuals and organizations supporting cardiovascular research (80% deduction for first €250, 40% for remainder for individuals)
5. Competitive European Research Grants: ERC Advanced Grants and other Horizon Europe funding for specific research projects

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

CNIC is a public-private cardiovascular research foundation that conducts basic, translational, and clinical research on cardiovascular diseases across five focused programmes. It delivers structured research training through the CNIC-JOVEN plan spanning secondary education to postdoctoral levels, manages a portfolio of cardiovascular diagnostic and therapeutic patents, and coordinates large-scale clinical studies in collaboration with industry and academic partners.

Product overview

CNIC (Centro Nacional de Investigaciones Cardiovasculares Carlos III) is an internationally recognized cardiovascular research excellence center that operates as a unified research institution rather than a commercial product company. Its portfolio consists of research programs (organized into five focused areas: atherosclerosis mechanisms, myocardial homeostasis, cardiovascular regeneration, cardiovascular-brain health, and technological development), training initiatives through the CNIC-JOVEN plan covering all educational levels, scientific publications including the annual Scientific Report and CNIC Pulse magazine, patent-protected intellectual property in cardiovascular diagnostics and therapeutics, and specialized training programs such as ACÉRCATE, InvesMIR, and MD-PhD. The institution focuses on understanding cardiovascular health and disease fundamentals and translating findings to patient care, offering its expertise and research outcomes rather than commercial products.

Differentiator

Problem solved

Functional benefit

Products and services

• CNIC-JOVEN Training Plan

Quantifiable outcome

• 20.5 million cardiovascular deaths per year globally according to WORLD HEART REPORT 2023
• +2 more outcomes

Named customers8 records

Segments1 record

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered major, core and minor.

• Banco SantandermajorStrategic or Co-development PartnerCollaborates on the PESA CNIC2-SANTANDER project (Early Detection of Subclinical Atherosclerosis and its Relationship with Risk Factors). Project evaluates genetic, molecular, and environmental determinants of atherosclerotic plaque characteristics in 3,000-5,000 individuals aged 40-54 using advanced cardiovascular imaging techniques. Led by Dr. Valentín Fuster.
• Ferrer Internacional S.A.majorStrategic or Co-development PartnerCollaborates on the Polypill/FOCUS project, developing a polypill for high-risk cardiovascular patients containing aspirin, a statin, and an ACE inhibitor. Aims to improve treatment adherence and reduce costs while improving availability in low-income countries.
• Icahn School of Medicine at Mount SinaimajorStrategic or Co-development PartnerCollaborates on the TANSNIP project (Trans-Atlantic Network to Study Stepwise Noninvasive Imaging as a Tool for Cardiovascular Prognosis and Prevention). Studies lifestyle modification interventions in populations with subclinical atherosclerotic disease.
• VU University Medical Center AmsterdammajorStrategic or Co-development PartnerCollaborates on the TANSNIP project alongside Icahn School of Medicine at Mount Sinai for international cardiovascular imaging research network.
• Sociedad Española de Cardiología (SEC)majorStrategic or Co-development PartnerFramework agreement for cooperation in biomedical research and training of specialized cardiologists. Joint programs include RES@CNIC SEC-CNIC, INVESMIR SEC-CNIC, CARDIOJOVEN SEC-CNIC, POST-MIR ARC-CNIC, and pathophysiology courses. SEC provides accreditation for medical training programs.
• Fundación Jiménez DíazcoreStrategic or Co-development PartnerCollaborative agreement for joint research programs, shared clinical trials, researcher exchange, and combined training of medical residents (MIR). Focuses on translational research from laboratory to patient.
• Fundación la CaixamajorStrategic or Co-development PartnerHosts the INPhINIT international predoctoral program as a Severo Ochoa excellence center. Program co-financed by European Commission through Horizon 2020 Marie Sklodowska-Curie Actions-COFUND.
• Fundación Jesús SerraminorStrategic or Co-development PartnerVisiting professors program bringing internationally recognized researchers to CNIC annually. Aims to strengthen scientific collaboration and initiate new research lines and projects.
• Comunidad de Madrid - Consejería de SanidadcoreStrategic or Co-development PartnerEstablished Scientific Research Laboratory in Human Cardiovascular Imaging at Hospital Carlos III. Supports priority research in human cardiovascular imaging due to high incidence of cardiovascular pathology.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Centro Nacional de Investigaciones Oncológicas (CNIO): Spain's national cancer research center, operating under the same Instituto de Salud Carlos III framework as CNIC. Directly comparable public-private nonprofit research institute model, focused on a different therapeutic area.
• Centro Cardiologico Monzino: Italian cardiovascular research center and hospital under IRCCS designation. Directly comparable dedicated cardiovascular research institute combining clinical care, translational research, and training.
• German Heart Center Munich (Deutsches Herzzentrum München): Specialized cardiovascular hospital and research center. Directly comparable dedicated cardiovascular specialty institution combining clinical cardiology, surgical care, and translational research.
• Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV): Spanish national network of cardiovascular research groups coordinated through Instituto de Salud Carlos III. Closely linked institutional network with overlapping researchers and shared funding structures.

Broad incumbents

• Inserm: French national institute of health and medical research, the European counterpart to CNIC's national research mission. Larger and broader, but operationally comparable as a publicly funded biomedical research organization with grant-driven funding.
• Max Delbrück Center for Molecular Medicine (MDC): German Helmholtz-affiliated molecular medicine research center. Comparable in scale and translational research focus, combining basic biomedical research with clinical translation in cardiovascular and metabolic disease.
• Karolinska Institutet Cardiovascular Research Group: Sweden's leading medical university with major cardiovascular research programs. Comparable as a translational cardiovascular research environment, though embedded in a broader academic medical center rather than a standalone institute.
• National Heart, Lung, and Blood Institute (NHLBI): US National Institutes of Health institute dedicated to cardiovascular, lung, and blood research. Comparable mission in cardiovascular research funding and direction, though much larger and embedded in a federal agency.

Regional players

• Montreal Heart Institute (Institut de Cardiologie de Montréal): Canadian specialized cardiovascular hospital and research center. Comparable scope as a dedicated cardiovascular specialty institution with strong research mandate, though operating in North America rather than Europe.
• Cedars-Sinai Smidt Heart Institute: Major US cardiovascular specialty hospital and research center with strong translational and imaging research. Comparable as a high-output cardiovascular research enterprise with clinical integration, though private US system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cnic_cardio
• YouTubeyoutube.com/channel/UCszQdG0s0uoKAnJj6KXbIZw
• LinkedInlinkedin.com/company/67529

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CNIC